Northern Trust
KRTX

Northern Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Northern Trust’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-159,328
Closed -$50.4M – 4509
2023
Q4 		$50.4M Buy
159,328
+1,767
+1% +$343K 0.01% 1003
2023
Q3 		$26.6M Buy
157,561
+13,566
+9% +$2.55M 0.01% 1350
2023
Q2 		$31.2M Sell
143,995
-147,913
-51% -$31.7M 0.01% 1280
2023
Q1 		$53M Buy
291,908
+22,659
+8% +$4.33M 0.01% 912
2022
Q4 		$52.9M Buy
269,249
+6,094
+2% +$1.31M 0.01% 893
2022
Q3 		$59.2M Buy
263,155
+31,275
+13% +$6.33M 0.01% 757
2022
Q2 		$29.3M Buy
231,880
+25,319
+12% +$2.91M 0.01% 1268
2022
Q1 		$26.2M Sell
206,561
-9,013
-4% -$1.01M ﹤0.01% 1482
2021
Q4 		$28.2M Sell
215,574
-3,217
-1% -$416K ﹤0.01% 1531
2021
Q3 		$26.8M Sell
218,791
-7,332
-3% -$846K ﹤0.01% 1579
2021
Q2 		$25.8M Buy
226,123
+46,741
+26% +$5.46M ﹤0.01% 1711
2021
Q1 		$21.6M Sell
179,382
-2,838
-2% -$322K ﹤0.01% 1764
2020
Q4 		$18.5M Sell
182,220
-3,557
-2% -$330K ﹤0.01% 1843
2020
Q3 		$14.4M Buy
185,777
+63,153
+52% +$5.38M ﹤0.01% 1869
2020
Q2 		$13.7M Sell
122,624
-4,322
-3% -$376K ﹤0.01% 1900
2020
Q1 		$9.14M Buy
126,946
+57,732
+83% +$4.94M ﹤0.01% 1926
2019
Q4 		$5.21M Buy
69,214
+2,729
+4% +$120K ﹤0.01% 2557
2019
Q3 		$1.08M Buy
+66,485
New +$1.29M ﹤0.01% 3368

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Northern Trust's KRTX Position: Q1 2024 in Review

Northern Trust sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 159,328 shares — an estimated $50.4M sold.

Northern Trust first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $59.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Northern Trust reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 159,328 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $50.4M.
  • Northern Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Northern Trust's Karuna Therapeutics, Inc. Common Stock position peaked at $59.2M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.